Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Number of holders
-
104
-
Total 13F shares, excl. options
-
37.9M
-
Shares change
-
+21.3M
-
Total reported value, excl. options
-
$819M
-
Value change
-
+$469M
-
Put/Call ratio
-
3.47
-
Number of buys
-
91
-
Number of sells
-
-12
-
Price
-
$21.60
Significant Holders of LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (LBPH) as of Q1 2024
113 filings reported holding LBPH - LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share as of Q1 2024.
LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (LBPH) has 104 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.9M shares
.
Largest 10 shareholders include FMR LLC (4.53M shares), Cormorant Asset Management, LP (3.35M shares), RA CAPITAL MANAGEMENT, L.P. (3.29M shares), FARALLON CAPITAL MANAGEMENT LLC (2.94M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.22M shares), WELLINGTON MANAGEMENT GROUP LLP (2.14M shares), BlackRock Inc. (1.87M shares), VANGUARD GROUP INC (1.72M shares), Point72 Asset Management, L.P. (1.38M shares), and Polar Capital Holdings Plc (1.31M shares).
This table shows the top 104 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.